FAST
42
-4
INTC
45
-2
LEN
19
-2
WY
50
3
PPG
41
-2
CAH
63
2
EL
30
-18
GE
65
-2
QRVO
10
-13
A
41
-3
DGX
44
-20
HBI
62
-2
KO
67
4
DVN
44
-11
TSCO
46
-4
WHR
48
-2
DOV
61
-14
FRT
50
2
MAS
51
-3
CVX
64
-5
FAST
42
-4
INTC
45
-2
LEN
19
-2
WY
50
3
PPG
41
-2
CAH
63
2
EL
30
-18
GE
65
-2
QRVO
10
-13
A
41
-3
DGX
44
-20
HBI
62
-2
KO
67
4
DVN
44
-11
TSCO
46
-4
WHR
48
-2
DOV
61
-14
FRT
50
2
MAS
51
-3
CVX
64
-5
Financhill
Back

Salesforce 10K Form

Sell
39

CRM
Salesforce

Last Price:
$280.48
Seasonality Move:
5.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRM News And Ratings

See the #1 stock for the next 7 days that we like better than CRM

CRM Financial Statistics

Sales & Book Value

Annual Sales: $37.9B
Cash Flow: $3.8B
Price / Cash Flow: 21.85
Annual Sales: $63.59
Price / Book: 4.38

Profitability

EPS (TTM): 6.36000
Net Income (TTM): $6.2B
Gross Margin: $29.3B
Return on Equity: 10.45%
Return on Assets: 6.42%

Salesforce Earnings Forecast

Key Salesforce Financial Ratios

  • The Gross Profit Margin over the past 25 years for CRM is 77.19%.
  • The Selling, General & Administrative Expenses for CRM have been equal to 42.47% of Gross Profit Margin.
  • The Research & Development expenses have been 14.50% of Revenue.
  • The Interest Expense is 13.87% of Operating Income.
  • The Net Earning history of CRM is 16.35% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 16 years.

Salesforce Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Software
Sector: Information Technology
Current Symbol: CRM
CUSIP: 79466L
Website: salesforce.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 1.06
Quick Ratio: 0.93

Price-to-Earnings

Trailing P/E Ratio: 43.87
Forward P/E Ratio: 22.21

CRM Technical Analysis vs Fundamental Analysis

Sell
39
Salesforce (CRM) is a Sell

Is Salesforce a Buy or a Sell?

  • Salesforce stock is rated a Sell
    The current Salesforce [CRM] share price is $279.03. The Score for CRM is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.